Design, Synthesis, and Activity of 2,6-Diphenoxypyridine-Derived Factor Xa Inhibitors

Citations Over Time

Abstract

A novel series of 2,6-diphenoxypyridines has been designed to inhibit factor Xa, a serine protease strategically located in the coagulation cascade. The evolution from the photochemically unstable bisamidine (Z,Z)-BABCH to potent bisamidine compounds with a pyridine heterocycle as the core scaffold has been achieved. The most potent compound in the series, 6h, has a Ki for human factor Xa of 12 nM. The selectivity of 6h against bovine trypsin and human thrombin was greater than 90- and 1000-fold, respectively. Two proposed modes of binding of 6h to factor Xa are made based on the crystal structures of 6h by itself and of 6h bound to bovine trypsin.

Related Papers

• → Structural features of a snake venom thrombin-like enzyme: thrombin and trypsin on a single catalytic platform?(2001)55 cited
• → Cleavage specificity of cucumisin, a serine protease, with synthetic substrates(2000)18 cited
• → Three recombinant serine proteinase inhibitors expressed from the coding region of the thrombin inhibitor dipetalogastin(2004)14 cited
• → Mesotrypsin/Trypsin IV Expression and Role of Serine Protease Activity in Response to Pathogenic or Commensal Forms of E. coli(2011)
• [Synthetic inhibitors of serine proteinases. 12. The inhibition of trypsin, plasmin and thrombin by 3-[amidinophenyl]-1-phenyl-propanone-(1) with substituents in the aliphatic intermediate chain].(1976)